HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Noriyuki Sato Selected Research

1- mono- O- acyl- 3- O- (alpha- D- sulfoquinovosyl)- glyceride

8/2012Anti-angiogenesis effect of 3'-sulfoquinovosyl-1'-monoacylglycerol via upregulation of thrombospondin 1.
5/2008Downregulation of Tie2 gene by a novel antitumor sulfolipid, 3'-sulfoquinovosyl-1'-monoacylglycerol, targeting angiogenesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Noriyuki Sato Research Topics

Disease

147Neoplasms (Cancer)
11/2021 - 01/2002
14Neoplasm Metastasis (Metastasis)
05/2017 - 01/2002
13Colonic Neoplasms (Colon Cancer)
11/2020 - 10/2005
12Colorectal Neoplasms (Colorectal Cancer)
11/2021 - 06/2004
12Osteosarcoma (Osteogenic Sarcoma)
10/2020 - 01/2003
11Sarcoma (Soft Tissue Sarcoma)
10/2020 - 08/2005
11Carcinoma (Carcinomatosis)
11/2017 - 05/2006
11Breast Neoplasms (Breast Cancer)
04/2017 - 02/2005
10Lung Neoplasms (Lung Cancer)
01/2017 - 02/2005
10Melanoma (Melanoma, Malignant)
07/2012 - 01/2004
7Renal Cell Carcinoma (Grawitz Tumor)
10/2020 - 04/2007
7Testicular Neoplasms (Testicular Cancer)
01/2020 - 06/2012
7Pancreatic Neoplasms (Pancreatic Cancer)
08/2019 - 01/2002
7Hypoxia (Hypoxemia)
12/2016 - 11/2009
6Adenocarcinoma
08/2019 - 10/2003
6Prostatic Neoplasms (Prostate Cancer)
01/2015 - 08/2007
6Squamous Cell Carcinoma (Epidermoid Carcinoma)
02/2011 - 08/2002
5Adenocarcinoma of Lung
01/2013 - 01/2002
5Synovial Sarcoma (Synovioma)
09/2012 - 08/2002
4Carcinogenesis
01/2020 - 01/2003
4Inflammation (Inflammations)
01/2016 - 11/2008
4Hyperthermia
11/2012 - 09/2009
4Urinary Bladder Neoplasms (Bladder Cancer)
12/2009 - 01/2004
4Stomach Neoplasms (Stomach Cancer)
01/2007 - 01/2004
3Necrosis
02/2020 - 01/2007
3Ovarian Neoplasms (Ovarian Cancer)
05/2016 - 01/2013
3Uterine Cervical Neoplasms (Cancer of the Cervix)
03/2016 - 04/2002
3Tics (Tic)
08/2013 - 03/2010
3Mouth Neoplasms (Oral Cancer)
02/2011 - 01/2009
3Hepatocellular Carcinoma (Hepatoma)
02/2009 - 09/2005
2Neuroblastoma
10/2016 - 01/2004
2Obesity
01/2016 - 04/2002
2Autoimmune Diseases (Autoimmune Disease)
07/2015 - 07/2002
2Atopic Dermatitis (Atopic Eczema)
12/2014 - 01/2014
2Ovarian Epithelial Carcinoma
12/2014 - 01/2013

Drug/Important Bio-Agent (IBA)

60AntigensIBA
01/2021 - 05/2002
59Peptides (Polypeptides)IBA
11/2021 - 05/2002
32Proteins (Proteins, Gene)FDA Link
01/2020 - 06/2002
22SurvivinIBA
02/2020 - 06/2002
14HLA-A24 AntigenIBA
10/2020 - 07/2002
13Protein Subunit VaccinesIBA
08/2019 - 06/2004
13HLA Antigens (Human Leukocyte Antigens)IBA
01/2019 - 08/2006
12EpitopesIBA
01/2018 - 06/2002
11Messenger RNA (mRNA)IBA
01/2020 - 01/2002
10Heat-Shock Proteins (Heat-Shock Protein)IBA
03/2018 - 01/2004
9Cancer VaccinesIBA
01/2014 - 05/2002
8Complementary DNA (cDNA)IBA
01/2013 - 01/2002
7HLA-A Antigens (HLA-A)IBA
08/2014 - 05/2002
7Monoclonal AntibodiesIBA
08/2014 - 01/2004
6Oxidoreductases (Dehydrogenase)IBA
04/2017 - 11/2012
6Histocompatibility Antigens Class IIBA
01/2017 - 04/2007
6DNA (Deoxyribonucleic Acid)IBA
04/2013 - 04/2002
6AntibodiesIBA
07/2012 - 08/2002
6AutoantibodiesIBA
05/2011 - 05/2005
6Inhibitor of Apoptosis ProteinsIBA
02/2011 - 02/2005
5Aldehyde Dehydrogenase 1 FamilyIBA
04/2017 - 10/2012
5Small Interfering RNA (siRNA)IBA
04/2016 - 10/2005
5Neoplasm Antigens (Tumor Antigens)IBA
01/2014 - 05/2003
4Transcription Factors (Transcription Factor)IBA
08/2016 - 01/2003
4VaccinesIBA
02/2016 - 04/2009
4Biological ProductsIBA
02/2016 - 01/2002
4EnzymesIBA
05/2015 - 09/2005
4OsteopontinIBA
12/2014 - 02/2003
3LigandsIBA
11/2021 - 01/2014
3incomplete Freund's adjuvantIBA
02/2020 - 06/2011
3Immune Checkpoint InhibitorsIBA
08/2019 - 01/2016
3Phosphotransferases (Kinase)IBA
11/2017 - 12/2005
3Oxygen (Dioxygen)IBA
04/2016 - 11/2009
3Aldehyde DehydrogenaseIBA
01/2016 - 07/2012
3CytokinesIBA
01/2016 - 05/2003
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2016 - 02/2003
3RecoverinIBA
01/2015 - 07/2002
3HLA-A2 Antigen (HLA A2 Antigen)IBA
08/2014 - 02/2008
3Coloring Agents (Dyes)IBA
10/2013 - 04/2011
3Biomarkers (Surrogate Marker)IBA
01/2013 - 06/2009
3MHC class II transactivator proteinIBA
11/2004 - 05/2003
2Single-Chain AntibodiesIBA
10/2020 - 08/2014
2Interferon-alpha (Interferon Alfa)IBA
02/2020 - 01/2013
2GemcitabineFDA Link
08/2019 - 10/2018
2T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2019 - 01/2016
2Sorting NexinsIBA
11/2017 - 07/2012
2CarcinogensIBA
11/2017 - 07/2012
2HSP40 Heat-Shock ProteinsIBA
10/2016 - 01/2016
2LeptinIBA
01/2016 - 04/2002
2Interleukin-6 (Interleukin 6)IBA
01/2016 - 01/2016
2ChemokinesIBA
02/2015 - 07/2002
2Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
01/2015 - 04/2013
2IntegrinsIBA
12/2014 - 02/2003
2HLA-B55 antigenIBA
08/2014 - 06/2009
2Membrane Proteins (Integral Membrane Proteins)IBA
10/2013 - 01/2003
2InterferonsIBA
01/2013 - 06/2009
21- mono- O- acyl- 3- O- (alpha- D- sulfoquinovosyl)- glycerideIBA
08/2012 - 05/2008
2N-propionyl-4-S-cysteaminylphenolIBA
07/2012 - 09/2010
2Caspase 3 (Caspase-3)IBA
07/2012 - 09/2009

Therapy/Procedure

54Immunotherapy
11/2020 - 05/2002
41Therapeutics
02/2020 - 01/2004
19Drug Therapy (Chemotherapy)
11/2020 - 08/2003
7Radiotherapy
01/2018 - 03/2010
2Heterologous Transplantation (Xenotransplantation)
01/2016 - 12/2014
2Aftercare (After-Treatment)
01/2013 - 01/2013